Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Clinical trial NCT00691028 · COMPLETED
Trial details
- NCT number
- NCT00691028
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-05-01
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.